|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | (2003.01) |
| A61K 48/005 | (2013.01) | ||
| C12N 15/86 | (2006.01) | ||
| C12N 15/86 | (2013.01) | ||
| C12N 9/64 | (2006.01) | ||
| C12N2750/14141 | (2013.01) | ||
| C12N 9/6421 | (2013.01) |
| (11) | Patento numeris | 3906066 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 20704633.5 |
| Europos patento paraiškos padavimo data | 2020-01-03 | |
| (97) | Europos patento paraiškos paskelbimo data | 2021-11-10 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-11-01 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2020/012131 |
| Data | 2020-01-03 |
| (87) | Numeris | WO 2020/142653 |
| Data | 2020-07-09 |
| (30) | Numeris | Data | Šalis |
| 201962788324 P | 2019-01-04 | US | |
| 201962834830 P | 2019-04-16 | US |
| (72) |
LIVINGSTON, Christine , US
WADSWORTH, Samuel , US
|
| (73) |
Ultragenyx Pharmaceutical Inc. ,
60 Leveroni Court, Novato, CA 94949,
US
|
| (54) | GENE THERAPY CONSTRUCTS FOR TREATING WILSON DISEASE |
| GENE THERAPY CONSTRUCTS FOR TREATING WILSON DISEASE |